정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
142 | Not yet recruiting | Traditional Chinese Medicine for Severe COVID-19 | COVID-19 | Drug: Traditional Chinese Medicine Prescription | Phase 3 | Xiyuan Hospital of China Academy of Chinese Medical Sciences | OTHER | 50 | All | ~ 85 Years | Hao Li, Beijing, Beijing, China |
141 | Recruiting | Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents | Corona Virus Infection | Biological: SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted) Drug: Normal Saline |
Early Phase 1 | Barbara Carlson, Oklahoma Medical Research Foundation | OTHER | 250 | All | 65 Years ~ 100 Years | Fran and Earl Ziegler College of Nursing, Oklahoma City, Oklahoma, United States |
140 | Withdrawn | Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients | COVID19 | Drug: Tranexamic acid Drug: Placebo oral tablet |
Phase 2 | University of Alabama at Birmingham | OTHER | 0 | All | 19 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States |
139 | Recruiting | Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection | Covid19 | Drug: Cytotoxic T Lymphocytes | Phase 1 | Thomas Jefferson University, Tevogen Bio Inc | OTHER | 24 | All | 18 Years | Thomas Jefferson University, Philadelphia, Pennsylvania, United States |
138 | Terminated | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | SARS-CoV 2 | Biological: CONVALESCENT PLASMA | Phase 2 | Azienda Ospedaliero, Universitaria Pisana | OTHER | 1 | All | 18 Years | Azienda Ospedaliero Universitaria Pisana, Pisa, Italy |
137 | Completed | TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients | Pneumonia, Viral | Biological: Convalescent plasma | Not Applicable | Istituto Superiore di Sanita, Gruppo Italiano Malattie EMatologiche dell'Adulto, Agenzia Italiana del Farmaco | OTHER | 474 | All | 18 Years | SOD Clinica Malattie Infettive Tropicali, Parassitologia, Epatiti Croniche - AOU Ospedali Riuniti di Ancona, Ancona, Italy Ospedale di Arezzo, Arezzo, Italy Clinica Malattie Infettive, Universita degli Studi di Bari, Bari, Italy Ospedale Papa Giovanni XXIII-Dip. emergenza, Urgenza e area critica, Bergamo, Italy UOC Malattie Infettive - AOU Bologna, Bologna, Italy UO PID Tossicologia Applicata - Dip. Scienze Biomediche e Biotecnologiche - Universita di Catania - AOU Policlinico Vittorio Emanuele, Catania, Italy Ospedale Citta di Castello, Citta Di Castello, Italy Ospedale di Empoli, Empoli, Italy UOC Malattie Infettive - ASUR Marche Area Vasta 4, Fermo, Italy UOC Malattie Infettive - AOU Ferrara, Ferrara, Italy Ospedale Santa Maria Annunziata, Firenze, Italy SOD Malattie Infettive e Tropicali - AOU Careggi, Firenze, Italy Dip.Medicina Clinica e Sperimentale - Policlinico "Riuniti" di Foggia, Foggia, Italy Nuovo Ospedale S. Giovanni Battista Usl Umbria2, Foligno, Italy U.O.C. Malattie Infettive ASL Frosinone, Frosinone, Italy U.O. Malattie Infettive IRCCS-Ospedale Policlinico San Martino, Genova, Italy Ospedale di Grosseto, Grosseto, Italy ASL 5 Spezzina - SC Malattie Infettive, La Spezia, Italy ASST Lecco - Malattie Infettive, Lecco, Italy Ospedale di Livorno, Livorno, Italy Ospedale di Lucca, Lucca, Italy S.C. Pneumologia e Utir ASST Mantova - Ospedale Carlo Poma, Mantova, Italy Ospedale Dell'Angelo - UOC Malattie Infettive, Mestre, Italy ASST Santi Paolo e Carlo, Milano, Italy Ospedale Luigi Sacco, Milano, Italy SC Malattie Infettive ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy Ospedale San Gerardo, Monza, Italy Malattie Infettive - AOU Federico II di Napoli, Napoli, Italy UOC Malattie Infettive ad indirizzo Respiratorio - PO Cotugno - AORN "Dei Colli", Napoli, Italy UOC Malattie Infettive e Tropicali - AOU Policlinico, Palermo, Italy Dip. Medicina Diagnost. e Servizi Fondazione IRCCS Policlinico San Matteo, Pavia, Italy Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy UOC Malattie Infettive - Azienda Ospedali Riuniti Marche Nord, Pesaro, Italy AOU Pisana, Pisa, Italy Ospedale Pistoia, Pistoia, Italy Ospedale Prato, Prato, Italy Malattie Infettive Ravenna, Ravenna, Italy UOC Malattie Infettive - AUSL Reggio Emilia, Reggio Emilia, Italy Malattie Infettive - Rimini Forli Cesena, Rimini, Italy Campus Bio Medico - UO Anestesia e Rianimazione, Roma, Italy ASL 1 Imperiese - SC Malattie Infettive, Sanremo, Italy ASL 2 Savonese - SC Malattie Infettive, Savona, Italy Ospedale di Siena, Siena, Italy Ospedale di Sondrio - dipartimento di Medicina, Sondrio, Italy AOU di Terni, Terni, Italy Ospedale Ca Foncello - UOC Malattie Infettive, Treviso, Italy A.O. Integrata Universita di Verona, Verona, Italy Ospedale Viareggio, Viareggio, Italy |
136 | Recruiting | Treat COVID-19 Patients With Regadenoson | Lung Inflammation | Drug: Regadenoson Other: Placebo Control |
Phase 2 | University of Maryland, Baltimore | OTHER | 40 | All | 18 Years | University of Maryland Medical Center, Baltimore, Maryland, United States |